Literature DB >> 25213720

Predictors of skin and soft tissue infections in HIV-infected outpatients in the community-associated methicillin-resistant Staphylococcus aureus era.

V Hemmige1, M McNulty, E Silverman, M Z David.   

Abstract

Skin and soft tissue infections (SSTIs) are common in the era of community-associated methicillin-resistant Staphylococcus aureus (MRSA) among human immunodeficiency virus (HIV)-infected patients, but the risk factors are not well defined. We sought to elucidate the risk factors for SSTI occurrence in an HIV cohort. This investigation was a retrospective, single-center cohort study, carried out during the period 2005-2009. In this cohort of 511 HIV-infected individuals, 133 SSTIs occurred in 87 individuals over 1,228.6 person-years of follow-up, for an incidence of 108 SSTIs/1,000 person-years [95 % confidence interval (CI) 87-135]. The incidence declined significantly over time (p < 0.01). In a multivariable Cox regression, diabetes [hazard ratio (HR) 2.01; 95 % CI 1.04-3.89], psoriasis (HR 5.77; 95 % CI 1.86-17.9), lymphedema (HR 6.84; 95 % CI 2.59-18.1), intravenous catheter presence (HR 3.38; 95 % CI 1.00-11.5), and HIV viral load greater than 1,000 copies/mL (HR 2.13; 95 % CI 1.33-3.41) were most strongly associated with development of the first SSTI. Trends toward an association between SSTI risk and Medicaid insurance (HR 1.67; 95 % CI 0.98-2.83) and sexually transmitted disease during follow-up (HR 1.66; 0.99-2.78) were present. CD4+ count and trimethoprim-sulfamethoxazole use were not associated with SSTI risk. HIV-infected individuals are at high risk for SSTIs. In a primarily urban, African-American cohort, we found that a number of immunologic and demographic factors were associated with SSTI risk.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25213720     DOI: 10.1007/s10096-014-2237-1

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  38 in total

Review 1.  Methicillin-resistant Staphylococcus aureus (MRSA) infections among HIV-infected persons in the era of highly active antiretroviral therapy: a review of the literature.

Authors:  A H Shadyab; N F Crum-Cianflone
Journal:  HIV Med       Date:  2012-01-25       Impact factor: 3.180

2.  Community-associated methicillin-resistant Staphylococcus aureus skin and soft-tissue infection in HIV-infected patients.

Authors:  T Tony Trinh; William R Short; Leonard A Mermel
Journal:  J Int Assoc Physicians AIDS Care (Chic)       Date:  2009-05-07

3.  Recurrence of skin and soft tissue infection caused by methicillin-resistant Staphylococcus aureus in a HIV primary care clinic.

Authors:  Christopher J Graber; Mark A Jacobson; Francoise Perdreau-Remington; Henry F Chambers; Binh An Diep
Journal:  J Acquir Immune Defic Syndr       Date:  2008-10-01       Impact factor: 3.731

4.  Emergence of methicillin-resistant Staphylococcus aureus USA300 genotype as a major cause of late-onset nosocomial pneumonia in intensive care patients in the USA.

Authors:  Timothy R Pasquale; Bonnie Jabrocki; Sara-Jane Salstrom; Timothy L Wiemken; Paula Peyrani; Nadia Z Haque; Ernesto G Scerpella; Kimbal D Ford; Marcus J Zervos; Julio A Ramirez; Thomas M File
Journal:  Int J Infect Dis       Date:  2013-02-01       Impact factor: 3.623

5.  Community-acquired methicillin-resistant Staphylococcus aureus in children with no identified predisposing risk.

Authors:  B C Herold; L C Immergluck; M C Maranan; D S Lauderdale; R E Gaskin; S Boyle-Vavra; C D Leitch; R S Daum
Journal:  JAMA       Date:  1998-02-25       Impact factor: 56.272

6.  The rise and fall of methicillin-resistant Staphylococcus aureus infections in HIV patients.

Authors:  Alicia I Hidron; Abeer Moanna; David Rimland
Journal:  AIDS       Date:  2011-04-24       Impact factor: 4.177

7.  Community-associated methicillin-resistant Staphylococcus aureus colonization burden in HIV-infected patients.

Authors:  Kyle J Popovich; Bala Hota; Alla Aroutcheva; Lisa Kurien; Janki Patel; Rosie Lyles-Banks; Amanda E Grasso; Andrej Spec; Kathleen G Beavis; Mary K Hayden; Robert A Weinstein
Journal:  Clin Infect Dis       Date:  2013-01-16       Impact factor: 9.079

8.  Emergence of multidrug-resistant, community-associated, methicillin-resistant Staphylococcus aureus clone USA300 in men who have sex with men.

Authors:  Binh An Diep; Henry F Chambers; Christopher J Graber; John D Szumowski; Loren G Miller; Linda L Han; Jason H Chen; Felice Lin; Jessica Lin; Tiffany HaiVan Phan; Heather A Carleton; Linda K McDougal; Fred C Tenover; Daniel E Cohen; Kenneth H Mayer; George F Sensabaugh; Françoise Perdreau-Remington
Journal:  Ann Intern Med       Date:  2008-01-30       Impact factor: 25.391

9.  Methicillin-resistant Staphylococcus aureus colonization, behavioral risk factors, and skin and soft-tissue infection at an ambulatory clinic serving a large population of HIV-infected men who have sex with men.

Authors:  John D Szumowski; Kenneth M Wener; Howard S Gold; Michael Wong; Lata Venkataraman; Carrie A Runde; Daniel E Cohen; Kenneth H Mayer; Sharon B Wright
Journal:  Clin Infect Dis       Date:  2009-07-01       Impact factor: 9.079

10.  Methicillin-resistant Staphylococcus aureus colonization of the groin and risk for clinical infection among HIV-infected adults.

Authors:  Philip J Peters; John T Brooks; Sigrid K McAllister; Brandi Limbago; H Ken Lowery; Gregory Fosheim; Jodie L Guest; Rachel J Gorwitz; Monique Bethea; Jeffrey Hageman; Rondeen Mindley; Linda K McDougal; David Rimland
Journal:  Emerg Infect Dis       Date:  2013-04       Impact factor: 6.883

View more
  8 in total

1.  Skin and Soft Tissue Infection in People Living With Human Immunodeficiency Virus in a Large, Urban, Public Healthcare System in Houston, Texas, 2009-2014.

Authors:  Vagish Hemmige; Cesar A Arias; Siavash Pasalar; Thomas P Giordano
Journal:  Clin Infect Dis       Date:  2020-04-15       Impact factor: 9.079

2.  Does active hepatitis C virus infection increase the risk for infection due to Staphylococcus aureus?

Authors:  A S Kaka; G A Filice; M Kuskowski; D M Musher
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2017-02-03       Impact factor: 3.267

Review 3.  Host factors that contribute to recurrent staphylococcal skin infection.

Authors:  Christopher P Montgomery; Michael Z David; Robert S Daum
Journal:  Curr Opin Infect Dis       Date:  2015-06       Impact factor: 4.915

4.  Decreasing Incidence of Skin and Soft-tissue Infections in 86 US Emergency Departments, 2009-2014.

Authors:  Ethan Morgan; Sam Hohmann; Jessica P Ridgway; Robert S Daum; Michael Z David
Journal:  Clin Infect Dis       Date:  2019-01-18       Impact factor: 20.999

5.  Hospitalization Rates and Causes Among Persons With HIV in the United States and Canada, 2005-2015.

Authors:  Thibaut Davy-Mendez; Sonia Napravnik; Brenna C Hogan; Keri N Althoff; Kelly A Gebo; Richard D Moore; Michael A Horberg; Michael J Silverberg; M John Gill; Heidi M Crane; Vincent C Marconi; Ronald J Bosch; Jonathan A Colasanti; Timothy R Sterling; W Christopher Mathews; Angel M Mayor; Ni Gusti Ayu Nanditha; Kate Buchacz; Jun Li; Peter F Rebeiro; Jennifer E Thorne; Ank Nijhawan; David van Duin; David A Wohl; Joseph J Eron; Stephen A Berry
Journal:  J Infect Dis       Date:  2021-06-15       Impact factor: 5.226

6.  The complex relationship between CD4 count, HIV viral load, trimethoprim-sulfamethoxazole prophylaxis, and skin-and-soft-tissue infection risk in patients with HIV: insights from a causal diagram and simulation study.

Authors:  V Hemmige; D S Lauderdale; M Z David
Journal:  Epidemiol Infect       Date:  2016-05-04       Impact factor: 4.434

7.  Importance of B Lymphocytes and the IgG-Binding Protein Sbi in Staphylococcus aureus Skin Infection.

Authors:  Fan Zhao; Anita S Chong; Christopher P Montgomery
Journal:  Pathogens       Date:  2016-01-27

8.  Recurrent skin and soft tissue infections in HIV-infected patients during a 5-year period: incidence and risk factors in a retrospective cohort study.

Authors:  Vagish Hemmige; Moira McNulty; Ethan Silverman; Michael Z David
Journal:  BMC Infect Dis       Date:  2015-10-26       Impact factor: 3.090

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.